|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments, at fair value | ||||||||||||||||
| Non-control/non-affiliate investments | ||||||||||||||||
| Affiliate investments | ||||||||||||||||
| Control Investment | ||||||||||||||||
| Total investments, at fair value | ||||||||||||||||
| Cash | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Receivable for investments sold | ||||||||||||||||
| Interest and dividend receivable | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Revolving lines of credit | ||||||||||||||||
| SBA debentures (net of deferred debt issuance costs of $0 and $20, respectively) | ||||||||||||||||
| Unsecured Notes (net of deferred debt issuance costs of $2,308 and $2,812, respectively) | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Distribution payable | ||||||||||||||||
| Payable to adviser and affiliates (Note 3) | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Affiliated entity | ||||||||||||||||
| Nonrelated party | ||||||||||||||||
| Accrued professional fees | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net Assets | ||||||||||||||||
| Preferred stock, par value of $0.01 per share, 2,000,000 shares authorized, -0- shares issued and outstanding as of June 30, 2026 and December 31, 2025,respectively | ||||||||||||||||
| Common stock, par value of $0.01 per share, 100,000,000 shares authorized, 13,398,078 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||
| Paid-in capital in excess of par | ||||||||||||||||
| Total distributable earnings (accumulated losses) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Number of common shares outstanding | ||||||||||||||||
| Net asset value per share | ||||||||||||||||
Loading...
